SCM
JNJ icon

Smead Capital Management’s Johnson & Johnson JNJ Stock Holding History

Smead Capital Management’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-259,139
Closed -$36.1M – 28
2019
Q2 		$36.1M Sell
259,139
-7,520
-3% -$1.04M 1.74% 24
2019
Q1 		$37.3M Sell
266,659
-8,132
-3% -$1.09M 1.89% 21
2018
Q4 		$35.5M Sell
274,791
-12,221
-4% -$1.7M 1.85% 23
2018
Q3 		$39.7M Sell
287,012
-7,220
-2% -$959K 1.79% 23
2018
Q2 		$35.7M Sell
294,232
-5,266
-2% -$657K 1.7% 24
2018
Q1 		$38.4M Sell
299,498
-104
-0% -$14.1K 1.86% 24
2017
Q4 		$41.9M Sell
299,602
-14,013
-4% -$1.95M 1.91% 22
2017
Q3 		$40.8M Sell
313,615
-4,280
-1% -$567K 1.94% 23
2017
Q2 		$42.1M Sell
317,895
-7,607
-2% -$970K 2.03% 23
2017
Q1 		$40.5M Sell
325,502
-6,865
-2% -$820K 2.04% 23
2016
Q4 		$38.3M Sell
332,367
-42,892
-11% -$4.95M 1.94% 24
2016
Q3 		$44.3M Sell
375,259
-23,247
-6% -$2.82M 2.11% 23
2016
Q2 		$48.3M Sell
398,506
-24,236
-6% -$2.75M 2.27% 23
2016
Q1 		$45.7M Sell
422,742
-49,137
-10% -$5.09M 1.98% 25
2015
Q4 		$39.7M Buy
471,879
+129,763
+38% +$13M 1.77% 25
2015
Q3 		$31.9M Buy
342,116
+78,444
+30% +$7.59M 1.7% 25
2015
Q2 		$25.7M Buy
263,672
+27,965
+12% +$2.8M 1.68% 27
2015
Q1 		$23.7M Buy
235,707
+37,616
+19% +$3.83M 1.74% 26
2014
Q4 		$22M Buy
198,091
+15,845
+9% +$1.67M 2.03% 23
2014
Q3 		$19.4M Buy
182,246
+7,008
+4% +$727K 2.09% 23
2014
Q2 		$18.3M Buy
175,238
+8,049
+5% +$814K 2% 24
2014
Q1 		$16.4M Buy
167,189
+20,731
+14% +$1.92M 1.98% 24
2013
Q4 		$13.4M Buy
146,458
+11,682
+9% +$1.08M 1.85% 24
2013
Q3 		$11.7M Buy
134,776
+21,272
+19% +$1.91M 1.89% 25
2013
Q2 		$9.74M Buy
+113,504
New +$9.63M 1.97% 25

Other funds holding JNJ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Smead Capital Management's JNJ Position: Q3 2019 in Review

Smead Capital Management sold out of Johnson & Johnson (JNJ) in Q3 2019, closing a stake of 259,139 shares — an estimated $36.1M sold.

Smead Capital Management first reported a position in JNJ in Q2 2013 and held it in 25 quarters. The position peaked at $48.3M in Q2 2016. 2,725 funds tracked by Wall St. Rank hold JNJ as of Q3 2019.

  • Smead Capital Management reported no remaining Johnson & Johnson position as of Q3 2019 after selling out during the quarter.
  • Smead Capital Management sold 259,139 Johnson & Johnson shares in Q3 2019, an estimated $36.1M.
  • Smead Capital Management first reported a position in Johnson & Johnson in Q2 2013 and held it in 25 quarters.
  • Smead Capital Management's Johnson & Johnson position peaked at $48.3M in Q2 2016.
  • 2,725 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2019.

Based on Smead Capital Management's 13F filing for Q3 2019, filed 25 Oct 2019.